Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine timing in children undergoing adenotonsillectomy
ChiCTR2200060118Phase 4Recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- May 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nalbuphine in obstructive sleep apnea hypopnea syndrome (OSAHS) (3 arms), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoints: stress hormones, inflammatory factors and 1 more. Started May 2022; status: recruiting.
02
Drugs
nalbuphine
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ChiCTR2200060118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060118.